Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and adults . In Canada, its access is overseen by Health Canada. This https://apolisdexamfetamineprice208076.designi1.com/63911813/lisdexamfetamine-in-canada-a-complete-guide